Ophthalmologists

• Glaucoma
• Ophthalmology
• Macular Degeneration
  Sub-Investigator – A Phase 3 B, Randomized, Active Controlled, Double-Masked, Single Dummy, Multi-Center Comparative Trial, In Parallel Groups, To Compare The Safety and Efficacy of Intravitreous Injections of Macugen Given Every 6 Weeks For 54 Weeks (To Be Extended To 102 Weeks As Indicated) Plus Sham Photodynamic Clinical Research: Therapy (PDT), To Macugen Plus PDT With Visudyne, In Subjects Curriculum Vitae, Page 3 Yu-Tang James Su, M.D. With Predominantly Classic Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) Protocol EOP1012. Version Date 28 August 2006. Study Closed.
• Cataracts
• Cataract Surgery

Endocrinologist

• Diabetes Care
• Diabetic Retinopathy
  Special interest in medical and surgical management of diabetic retinopathy, macular degeneration, retinal vascular disorder, macular pucker, macular hole, and retinal detachment.

Surgeons

• General Surgery